BRUKER CORPORATION (NASDAQ:BRKR) Files An 8-K Regulation FD Disclosure

ME Staff 8-k
-
0

BRUKER CORPORATION (NASDAQ:BRKR) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.

As previously announced, Bruker Corporation (the “Company”) will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 9, 2017 at 8:00 a.m. Pacific time. A live audio webcast of the presentation will be available through the Investor section of the Company’s website at http://ir.bruker.com. A copy of the Company’s presentation materials is attached hereto as Exhibit 99.1.

The presentation materials are being furnished to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified therein as being incorporated by reference therein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. 99.1 January 9, 2017 Presentation at the 35th Annual J.P. Morgan Healthcare Conference.



About BRUKER CORPORATION (NASDAQ:BRKR)

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive (CBRNE) detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.

BRUKER CORPORATION (NASDAQ:BRKR) Recent Trading Information

BRUKER CORPORATION (NASDAQ:BRKR) closed its last trading session up +0.17 at 22.21 with 522,762 shares trading hands.